Latus Pharma ApS: Financial statements 2017
CVR: 36974214
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Latus Pharma ApS (CVR 36974214) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 10,800 and a net result of DKK -64,823. The profit margin was -600.2%. Equity in the 2017 report amounted to DKK 135,317. The solvency ratio was 100%.
- Revenue
- DKK 10,800
- Gross Profit
- DKK -64,938
- Profit/Loss
- DKK -64,823
- Equity
- DKK 135,317
- Total Assets
- DKK 135,317
Official annual report
Keep an eye on Latus Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Latus Pharma ApS has published its interim report for the period July 28, 2015 – December 31, 2016.
About Latus Pharma ApS
Latus Pharma ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 2015. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jørgen Wittendorff. The company is owned by Jørgen Wittendorff. In 2025, the company reported revenue of DKK -6,991 and a net result of DKK -6,991 compared with DKK -6,897 the year before. Equity in the 2025 report amounted to DKK 82,569.